أعرض في EDS

265 POSTER A MEK1/2 inhibitor, AZD6244 (ARRY-142886), shows beneficial effects when combined with standards of care or novel therapies – mechanistic characterisation suggests a role for apoptosis

التفاصيل البيبلوغرافية
العنوان: 265 POSTER A MEK1/2 inhibitor, AZD6244 (ARRY-142886), shows beneficial effects when combined with standards of care or novel therapies – mechanistic characterisation suggests a role for apoptosis
المؤلفون: Robert W. Wilkinson, N. Haupt, M. Cockerhill, N.J. Curtis, A. Logie, B.R. Davies, Sarah V. Holt, J.S. McKay, D.M. Hickinson, Paul D. Smith
المصدر: European Journal of Cancer Supplements. 6:86
بيانات النشر: Elsevier BV, 2008.
سنة النشر: 2008
مصطلحات موضوعية: Cancer Research, Oncology, business.industry, Apoptosis, Medicine, Pharmacology, business, Beneficial effects
تدمد: 1359-6349
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1a7106448830fab424e9aebd5934b10c
https://doi.org/10.1016/s1359-6349(08)72199-2
حقوق: OPEN
رقم الأكسشن: edsair.doi...........1a7106448830fab424e9aebd5934b10c
قاعدة البيانات: OpenAIRE
الوصف
تدمد:13596349